Cargando…

Major life events, stress appraisal, and migraine: results of the American Migraine Prevalence and Prevention (AMPP) study

Detalles Bibliográficos
Autores principales:	Manack, AN, Serrano, D, Turkel, CC, Lipton, RB, Buse, DC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620519/ http://dx.doi.org/10.1186/1129-2377-14-S1-P9

Ejemplares similares

Acute treatment optimization for migraine: results of the American migraine prevalence and prevention (AMPP) study
por: Lipton, RB, et al.
Publicado: (2013)

Adding acute treatments for patients on triptans: Results of the American Migraine Prevalence & Prevention (AMPP) study
por: Lipton, RB, et al.
Publicado: (2013)

Consistency vs. switching triptan treatment and headache-related disability: Results of the American migraine prevalence & prevention study
por: Buse, DC, et al.
Publicado: (2013)

A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache‐Related Disability
por: Lipton, Richard B., et al.
Publicado: (2016)

Burden of migraine related to menses: results from the AMPP study
por: Pavlović, Jelena M, et al.
Publicado: (2015)

Knowledge, attitudes and clinical practice regarding behavioral treatments and psychological issues in migraine: a survey of AHS members
por: Buse, DC, et al.
Publicado: (2013)

The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program
por: Silberstein, S, et al.
Publicado: (2013)

Depression and risk of transformation of episodic to chronic migraine
por: Ashina, Sait, et al.
Publicado: (2012)

Defining the Differences Between Episodic Migraine and Chronic Migraine
por: Katsarava, Zaza, et al.
Publicado: (2011)

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT
por: Aurora, SK, et al.
Publicado: (2013)

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
por: Diener, HC, et al.
Publicado: (2013)

The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results
por: Adams, Aubrey Manack, et al.
Publicado: (2015)

Migraine headache is present in the aura phase – a prospective study
por: Hansen, JM, et al.
Publicado: (2013)

Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale
por: Lipton, Richard B., et al.
Publicado: (2017)

EHMTI-0169. Trajectories of headache days over one year (5 waves) in chronic and episodic migraineurs participating in the chronic migraine epidemiology and outcomes (cameo) study
por: Lipton, RB, et al.
Publicado: (2014)

Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study
por: Lipton, Richard B., et al.
Publicado: (2019)

Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Lipton, Richard B., et al.
Publicado: (2019)

Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Buse, Dawn C., et al.
Publicado: (2019)

Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Buse, Dawn C., et al.
Publicado: (2023)

Survey of the differences between Migraine and MOH pre-existing migraine
por: Igarashi, H
Publicado: (2013)

OnabotulinumtoxinA for chronic migraine treatment: 75% responder analysis from double-blind, randomized, placebo-controlled phase of PREEMPT
por: Dodick, D, et al.
Publicado: (2013)

Bilateral jaw dislocation following botulinim toxin type A treatment for chronic migraine
por: Forbes, RB, et al.
Publicado: (2013)

The borderline between cluster headache and migraine: does cluster-migraine exist?
por: Lisotto, C, et al.
Publicado: (2013)

Evaluation of vestibular evoked myogenic potentials in migraine and migrainous vertigo patients
por: ÇatýkerÜtkür, B, et al.
Publicado: (2013)

Imaging the premonitory phase of migraine - new insights into generation of the migraine attack
por: Maniyar, FH, et al.
Publicado: (2013)

Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Dodick, David W., et al.
Publicado: (2016)

The Effect of Psychiatric Comorbidities on Headache‐Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Lipton, Richard B., et al.
Publicado: (2020)

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program
por: Aurora, SK, et al.
Publicado: (2014)

Migraine management in pregnancy
por: Jalilian, Nasrin, et al.
Publicado: (2012)

The clincal characteristics of abdominal migraine and risk factors for developing migraine later in childhood
por: Lee, KH, et al.
Publicado: (2013)

High prevalence of right to left shunt in women with chronic migraine
por: Larrosa, D, et al.
Publicado: (2013)

Zonisamide is effective in the preventive therapy of chronic migraine
por: Belvis, R, et al.
Publicado: (2013)

Relationship between migraine and malocclusion
por: Takeuchi, M, et al.
Publicado: (2013)

The comorbidity between migraine and hypothyroidism
por: Lisotto, C, et al.
Publicado: (2013)

P014. Migraine and hypnosis
por: Ardore, Marco, et al.
Publicado: (2015)

Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
por: Blumenfeld, Andrew M., et al.
Publicado: (2023)

Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura
por: Antonova, M, et al.
Publicado: (2013)

Menstrual migraine, migraine and contraceptions, migraine and pregnancy and migraine triggers
por: MacGregor, Anne
Publicado: (2013)

Analysis of subjects with menstrually related migraine vs. Non-menstrually related migraine treated with MAP0004
por: Aurora, S, et al.
Publicado: (2013)

P060. Vitamin D deficiency in episodic migraine, chronic migraine and medication-overuse headache patients
por: Iannacchero, Rosario, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_alvtrj8n7mrqtqcm8ph0n9hku4